Beth Taylor Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Beth Taylor.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Beth Taylor. Beth Taylor is VP- Finance & CFO in BIOANALYTICAL SYSTEMS INC ($BASI) and Corporate Controller in ENDOCYTE INC ($ECYT) and VP Finance & Chief Acctg Off in ENDOCYTE INC ($ECYT) and VP Finance & Chief Acctg Offcr in ENDOCYTE INC ($ECYT).
Latest Insider Trading Transactions of Beth Taylor
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11 2021 | BASI | Inotiv, Inc. | Taylor Beth | VP- Finance & CFO | Grant | A | 0.00 | 880 | 0 | 35,175 | 34.3 K to 35.2 K (+2.57 %) |
| Mar 05 2021 | BASI | BIOANALYTICAL SYST ... | Taylor Beth | VP- Finance & CFO | Buy | P | 17.70 | 5,000 | 88,500 | 34,295 | 29.3 K to 34.3 K (+17.07 %) |
| Mar 05 2021 | BASI | BIOANALYTICAL SYST ... | Taylor Beth | VP- Finance & CFO | Buy | P | 17.70 | 5,000 | 88,500 | 34,295 | 29.3 K to 34.3 K (+17.07 %) |
| Dec 04 2020 | BASI | BIOANALYTICAL SYST ... | Taylor Beth | VP- Finance & CFO | Grant | A | 0.00 | 5,995 | 0 | 29,295 | 23.3 K to 29.3 K (+25.73 %) |
| Jun 11 2020 | BASI | BIOANALYTICAL SYST ... | Taylor Beth | VP- Finance & CFO | Grant | A | 0.00 | 10,000 | 0 | 23,300 | 13.3 K to 23.3 K (+75.19 %) |
| May 21 2020 | BASI | BIOANALYTICAL SYST ... | Taylor Beth | VP- Finance & CFO | Buy | P | 4.52 | 3,300 | 14,916 | 13,300 | 10 K to 13.3 K (+33.00 %) |
| May 21 2020 | BASI | BIOANALYTICAL SYST ... | Taylor Beth | VP- Finance & CFO | Buy | P | 4.42 | 4,933 | 21,804 | 10,000 | 5.1 K to 10 K (+97.36 %) |
| May 21 2020 | BASI | BIOANALYTICAL SYST ... | Taylor Beth | VP- Finance & CFO | Buy | P | 4.38 | 5,067 | 22,193 | 5,067 | 0 to 5.1 K |
| Dec 21 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Option Exercise | D | 3.01 | 25,000 | 75,250 | 0 | |
| Dec 21 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Option Exercise | D | 2.16 | 15,000 | 32,400 | 0 | |
| Dec 21 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Option Exercise | D | 3.21 | 12,969 | 41,630 | 0 | |
| Dec 21 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Option Exercise | D | 3.18 | 3,750 | 11,925 | 0 | |
| Dec 21 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Option Exercise | D | 11.11 | 10,850 | 120,544 | 0 | |
| Dec 21 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Option Exercise | D | 9.86 | 9,132 | 90,042 | 0 | |
| Dec 21 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Option Exercise | D | 7.41 | 23,560 | 174,580 | 0 | |
| Dec 21 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Sell | D | 24.00 | 12,500 | 300,000 | 0 | 12.5 K to 0 (-100.00 %) |
| Dec 21 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Sell | D | 24.00 | 15,000 | 360,000 | 0 | 15 K to 0 (-100.00 %) |
| Dec 21 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Sell | D | 24.00 | 7,500 | 180,000 | 0 | 7.5 K to 0 (-100.00 %) |
| Dec 21 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Sell | D | 24.00 | 1,875 | 45,000 | 0 | 1.9 K to 0 (-100.00 %) |
| Dec 21 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Sell | D | 24.00 | 1,875 | 45,000 | 0 | 1.9 K to 0 (-100.00 %) |
| Dec 21 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Sell | D | 24.00 | 1,250 | 30,000 | 0 | 1.3 K to 0 (-100.00 %) |
| Dec 21 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Sell | D | 24.00 | 59,509 | 1,428,216 | 0 | 59.5 K to 0 (-100.00 %) |
| Dec 19 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Option Exercise | M | 2.16 | 5,000 | 10,800 | 15,000 | |
| Dec 19 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Option Exercise | M | 3.21 | 9,531 | 30,595 | 12,969 | |
| Dec 19 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Option Exercise | M | 3.18 | 3,750 | 11,925 | 3,750 | |
| Dec 19 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Option Exercise | M | 5.10 | 9,000 | 45,900 | 0 | |
| Dec 19 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Option Exercise | M | 9.86 | 5,500 | 54,230 | 9,132 | |
| Dec 19 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Option Exercise | M | 3.55 | 16,073 | 57,059 | 0 | |
| Dec 19 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Gift | G | 0.00 | 1,250 | 0 | 1,250 | 0 to 1.3 K |
| Dec 19 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Gift | G | 0.00 | 3,186 | 0 | 98,259 | 101.4 K to 98.3 K (-3.14 %) |
| Dec 19 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Gift | G | 0.00 | 1,250 | 0 | 101,445 | 102.7 K to 101.4 K (-1.22 %) |
| Dec 19 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Gift | G | 0.00 | 2,500 | 0 | 102,695 | 105.2 K to 102.7 K (-2.38 %) |
| Dec 19 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Buy | M | 2.16 | 5,000 | 10,800 | 105,195 | 100.2 K to 105.2 K (+4.99 %) |
| Dec 19 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Buy | M | 3.21 | 9,531 | 30,595 | 100,195 | 90.7 K to 100.2 K (+10.51 %) |
| Dec 19 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Buy | M | 3.18 | 3,750 | 11,925 | 90,664 | 86.9 K to 90.7 K (+4.31 %) |
| Dec 19 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Buy | M | 5.10 | 9,000 | 45,900 | 86,914 | 77.9 K to 86.9 K (+11.55 %) |
| Dec 19 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Buy | M | 9.86 | 5,500 | 54,230 | 77,914 | 72.4 K to 77.9 K (+7.60 %) |
| Dec 19 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Buy | M | 3.55 | 16,073 | 57,059 | 72,414 | 56.3 K to 72.4 K (+28.53 %) |
| Oct 09 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Sell | S | 15.56 | 7,022 | 109,287 | 56,341 | 63.4 K to 56.3 K (-11.08 %) |
| Aug 29 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Sell | S | 20.00 | 7,892 | 157,840 | 63,363 | 71.3 K to 63.4 K (-11.08 %) |
| Aug 22 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Sell | S | 18.20 | 285 | 5,187 | 71,255 | 71.5 K to 71.3 K (-0.40 %) |
| Feb 08 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Option Exercise | A | 3.01 | 25,000 | 75,250 | 25,000 | |
| Feb 08 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Grant | A | 0.00 | 12,500 | 0 | 71,540 | 59 K to 71.5 K (+21.17 %) |
| Feb 08 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Payment of Exercise | F | 3.00 | 484 | 1,452 | 59,040 | 59.5 K to 59 K (-0.81 %) |
| Feb 06 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Payment of Exercise | F | 3.12 | 869 | 2,711 | 59,524 | 60.4 K to 59.5 K (-1.44 %) |
| Feb 06 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Payment of Exercise | F | 3.12 | 890 | 2,777 | 60,393 | 61.3 K to 60.4 K (-1.45 %) |
| Oct 06 2017 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Grant | A | 0.00 | 30,000 | 0 | 61,283 | 31.3 K to 61.3 K (+95.90 %) |
| Feb 03 2017 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Option Exercise | A | 2.16 | 20,000 | 43,200 | 20,000 | |
| Feb 03 2017 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Grant | A | 0.00 | 10,000 | 0 | 31,283 | 21.3 K to 31.3 K (+46.99 %) |
| Aug 22 2016 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Option Exercise | A | 3.21 | 22,500 | 72,225 | 22,500 | |
| Aug 22 2016 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Grant | A | 0.00 | 3,750 | 0 | 21,283 | 17.5 K to 21.3 K (+21.39 %) |
| Feb 08 2016 | ECYT | ENDOCYTE INC | Taylor Beth | Corporate Controlle ... | Option Exercise | A | 3.18 | 7,500 | 23,850 | 7,500 | |
| Feb 08 2016 | ECYT | ENDOCYTE INC | Taylor Beth | Corporate Controlle ... | Payment of Exercise | F | 3.02 | 525 | 1,586 | 16,482 | 17 K to 16.5 K (-3.09 %) |
| Feb 08 2016 | ECYT | ENDOCYTE INC | Taylor Beth | Corporate Controlle ... | Grant | A | 0.00 | 3,750 | 0 | 17,007 | 13.3 K to 17 K (+28.29 %) |
| Mar 02 2012 | ECYT | ENDOCYTE INC | Taylor Beth | Corporate Controlle ... | Option Exercise | A | 3.55 | 16,073 | 57,059 | 16,073 |
Page: 1